Pankam Tippawan, Kerr Stephen J, Teeratakulpisan Nipat, Rodbamrung Piyanee, Wongkanya Rapeeporn, Keelawat Somboon, Ruangritchankul Komkrit, Hongchookiat Piranun, Watanapokasin Ramida, Phanuphak Nittaya
The Thai Red Cross AIDS Research Centre, Bangkok, Thailand; Department of Biochemistry, Faculty of Medicine, Srinakharinwirot University, Bangkok 10110, Thailand.
HIV-NAT, Bangkok, Thailand; The Kirby Institute, University of New South Wales, Sydney, Australia.
Papillomavirus Res. 2017 Jun;3:149-154. doi: 10.1016/j.pvr.2017.04.006. Epub 2017 May 5.
Men who have sex with men (MSM) are at high risk of developing human papillomavirus (HPV)-related anal cancer. We compared HPV genotypes in anal tissues (Bx) and anal liquid-based cytology fluid (LBC) from HIV-positive and HIV-negative MSM.
Bx (32 normal, 41 low-grade squamous intraepithelial lesions (LSIL) and 22 high-grade squamous intraepithelial lesions (HSIL)), along with LBC from the same visit, were selected from 61 HIV-positive and 34 HIV-negative MSM who enrolled into a prospective cohort in Bangkok, Thailand. HPV genotyping was performed on Bx and LBC.
Any HPV and high-risk HPV (HR-HPV) prevalence were 63.2% and 60.0% in Bx and 71.6% and 62.1% in LBC, respectively. HIV-positive MSM had higher rates of HR-HPV genotypes detection (70.5% vs. 47.1%, p=0.03) in LBC than HIV-negative MSM. HPV16 (27%) was the most common HR-HPV found in HSIL tissue. In HIV-positive MSM, the frequency of HR-HPV detection increased with histopathologic grading in both Bx and LBC samples. HSIL was associated with the presence of any HR-HPV(OR 7.6 (95%CI 1.8-31.9); P=0.006) in LBC and in Bx((OR 5.6 (95%CI 1.4-22.7); P=0.02).
Our data strongly support the integration of HR-HPV screening on LBC samples, along with HPV vaccination, into an anal cancer prevention program.
男男性行为者(MSM)患人乳头瘤病毒(HPV)相关肛门癌的风险很高。我们比较了HIV阳性和HIV阴性MSM的肛门组织(Bx)和肛门液基细胞学液(LBC)中的HPV基因型。
从泰国曼谷一项前瞻性队列研究中纳入的61名HIV阳性和34名HIV阴性MSM中,选取Bx(32例正常、41例低级别鳞状上皮内病变(LSIL)和22例高级别鳞状上皮内病变(HSIL))以及同一就诊时的LBC。对Bx和LBC进行HPV基因分型。
Bx中任何HPV和高危HPV(HR-HPV)的患病率分别为63.2%和60.0%,LBC中分别为71.6%和62.1%。HIV阳性MSM的LBC中HR-HPV基因型检测率(70.5%对47.1%,p = 0.03)高于HIV阴性MSM。HPV16(27%)是HSIL组织中最常见的HR-HPV。在HIV阳性MSM中,Bx和LBC样本中HR-HPV检测频率均随组织病理学分级增加。HSIL与LBC和Bx中存在任何HR-HPV相关(LBC中OR 7.6(95%CI 1.8 - 31.9);P = 0.006),Bx中(OR 5.6(95%CI 1.4 - 22.7);P = 0.02)。
我们的数据有力支持将LBC样本的HR-HPV筛查与HPV疫苗接种纳入肛门癌预防计划。